These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34235674)

  • 1. Antimicrobial Susceptibility Testing for Mycobacterium sps in High-Throughput Format.
    Pérez-Herrán E; Mendoza A
    Methods Mol Biol; 2021; 2314():637-648. PubMed ID: 34235674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis High-Throughput Screening.
    White EL; Tower NA; Rasmussen L
    Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility testing for Mycobacterium sp.
    Blanco-Ruano D; Roberts DM; Gonzalez-Del-Rio R; Álvarez D; Rebollo MJ; Pérez-Herrán E; Mendoza A
    Methods Mol Biol; 2015; 1285():257-68. PubMed ID: 25779321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high throughput methodology for susceptibility testing of Mycobacterium tuberculosis isolates.
    Rampersad T; Makume M; Sobia P; Willem Sturm A
    J Microbiol Methods; 2018 Mar; 146():64-67. PubMed ID: 29410256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis.
    Mak PA; Rao SP; Ping Tan M; Lin X; Chyba J; Tay J; Ng SH; Tan BH; Cherian J; Duraiswamy J; Bifani P; Lim V; Lee BH; Ling Ma N; Beer D; Thayalan P; Kuhen K; Chatterjee A; Supek F; Glynne R; Zheng J; Boshoff HI; Barry CE; Dick T; Pethe K; Camacho LR
    ACS Chem Biol; 2012 Jul; 7(7):1190-7. PubMed ID: 22500615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput screening assay based on automated microscopy for monitoring antibiotic susceptibility of Mycobacterium tuberculosis phenotypes.
    Kalsum S; Andersson B; Das J; Schön T; Lerm M
    BMC Microbiol; 2021 Jun; 21(1):167. PubMed ID: 34090328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining Minimum Inhibitory Concentrations in Liquid Cultures or on Solid Medium.
    Wang Q; Boshoff HIM
    Methods Mol Biol; 2021; 2314():595-609. PubMed ID: 34235672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model.
    Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA
    Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
    Yamazaki T; Sato N; Yamashita K; Okazawa Y; Miyao H; Tanno K
    Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reliability of bioluminescent assay (ATP method) for testing antimicrobial susceptibility of Mycobacterium tuberculosis].
    Yamazaki T; Sato N; Yamashita K; Okazawa Y; Araki H; Miwa A
    Rinsho Byori; 2003 Mar; 51(3):194-200. PubMed ID: 12707990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.
    Speer A; Shrestha TB; Bossmann SH; Basaraba RJ; Harber GJ; Michalek SM; Niederweis M; Kutsch O; Wolschendorf F
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1089-91. PubMed ID: 23254420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2015; 1285():293-315. PubMed ID: 25779324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria.
    Beckers B; Lang HR; Schimke D; Lammers A
    Eur J Clin Microbiol; 1985 Dec; 4(6):556-61. PubMed ID: 3937733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?
    Schön T; Köser CU; Werngren J; Viveiros M; Georghiou S; Kahlmeter G; Giske C; Maurer F; Lina G; Turnidge J; van Ingen J; Jankovic M; Goletti D; Cirillo DM; Santin M; Cambau E;
    Clin Microbiol Infect; 2020 Nov; 26(11):1453-1455. PubMed ID: 32768492
    [No Abstract]   [Full Text] [Related]  

  • 19. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem.
    Goldman RC
    Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages.
    Sorrentino F; Gonzalez del Rio R; Zheng X; Presa Matilla J; Torres Gomez P; Martinez Hoyos M; Perez Herran ME; Mendoza Losana A; Av-Gay Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):640-5. PubMed ID: 26503663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.